Senestech (SNES) Earning Somewhat Favorable Press Coverage, Report Finds
News coverage about Senestech (NASDAQ:SNES) has been trending somewhat positive this week, Accern reports. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Senestech earned a daily sentiment score of 0.09 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.9111522439659 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Senestech (SNES) traded down 3.66% during trading on Friday, reaching $1.84. 83,628 shares of the company’s stock were exchanged. The stock has a 50-day moving average of $1.88 and a 200-day moving average of $1.88. Senestech has a 52 week low of $1.54 and a 52 week high of $10.69. The stock’s market capitalization is $19.00 million.
Senestech (NASDAQ:SNES) last issued its earnings results on Thursday, August 10th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.28) by ($0.07). The firm had revenue of $0.01 million for the quarter, compared to analysts’ expectations of $0.10 million. On average, equities research analysts anticipate that Senestech will post ($1.30) EPS for the current year.
Separately, Zacks Investment Research raised shares of Senestech from a “sell” rating to a “hold” rating in a research report on Thursday, July 13th.
COPYRIGHT VIOLATION NOTICE: “Senestech (SNES) Earning Somewhat Favorable Press Coverage, Report Finds” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/10/08/senestech-snes-earning-somewhat-favorable-press-coverage-report-finds.html.
In other news, COO Andrew Altman bought 20,000 shares of the company’s stock in a transaction dated Friday, August 18th. The shares were purchased at an average price of $2.77 per share, for a total transaction of $55,400.00. Following the completion of the purchase, the chief operating officer now owns 2,600 shares in the company, valued at approximately $7,202. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Grover T. Wickersham bought 15,000 shares of the company’s stock in a transaction dated Tuesday, July 25th. The stock was purchased at an average price of $2.85 per share, for a total transaction of $42,750.00. Following the purchase, the director now owns 238,600 shares of the company’s stock, valued at approximately $680,010. The disclosure for this purchase can be found here. In the last quarter, insiders bought 54,100 shares of company stock worth $155,730 and sold 25,411 shares worth $57,893. Corporate insiders own 27.40% of the company’s stock.
SenesTech, Inc is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest’s technology and approach targets the reproductive capabilities of both sexes.
Receive News & Stock Ratings for Senestech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech Inc. and related stocks with our FREE daily email newsletter.